Review of Cannabinoid Clinical Trials for Mental Health Treatment
This cannabinoid clinical trials mental health treatment review summarizes current evidence on cannabinoids' efficacy and safety for mental health disorders. The review highlights consistent adverse effects reported in trials. Careful clinical monitoring…
Cannabinoids Show Short-Term Promise for Sleep Apnea, But Evidence Remains Too Thin for Clinical Use
A cannabinoids sleep apnea systematic review shows mostly positive short-term outcomes, including reduced apnea hypopnea index and improved daytime sleepiness. However, adverse events occurred in 70-80% of participants, raising safety concerns. The…
Medical Cannabis for Arthritis Pain: What the Evidence Really Shows
Despite promising preclinical and observational evidence, medical cannabis rheumatic pain treatment lacks high-quality clinical trials. This 2024 review highlights the gap between patient use and clinical evidence. Clinicians should engage patients…
CBD and Anxiety: Promising Signal, Weak Evidence Base
The cbd anxiety clinical trials 2024 review reveals most studies are exploratory with varied designs and small samples. Evidence supporting CBD for anxiety disorders remains weak and inconclusive. This review highlights the urgent need for robust…
Assessment of Clinical Factors Predicting Nabilone Response for Agitation in Alzheimer’s
This study investigates nabilone response predictors in treating agitation in Alzheimer's disease. Researchers analyzed clinical factors influencing treatment outcomes. Understanding these predictors may guide personalized cannabinoid therapy for…
Investigating Cannabinoids for Inflammation and Sickle Cell Disease Pain
This protocol outlines a randomized controlled trial investigating dronabinol sickle cell disease pain management. The study evaluates cannabinoids for inflammation and pain reduction. It aims to provide evidence for safer alternatives to opioids in…
Cannabidiol Blood Metabolite Levels and EEG Changes in Autism
This study on autism spectrum disorder cannabidiol research reveals that CBD blood metabolite levels are associated with EEG changes. Boys with autism showed improvements in visuomotor and non-verbal cognitive abilities after cannabidiol treatment. These…
Understanding the Effects and Safety of CBD-Rich Therapies
Osteoarthritis is a common inflammatory and degenerative joint disease characterized by chronic pain. This article reviews the effects and safety of a CBD-rich treatment for osteoarthritis. Clinical trials suggest CBD may offer a safer alternative for…
Cannabis effects on cardiovascular health: Evidence, gaps, and future directions
Cannabis cardiovascular safety concerns are increasingly important as use expands globally. Current evidence shows mixed results but a stronger link to atrial arrhythmias. This review highlights critical gaps in knowledge and the need for cautious…
Investigational Drugs in PTSD: Emerging Clinical Evidence
The endocannabinoid system and PTSD clinical evidence reveal promising investigational drugs targeting neurobiological pathways. PTSD remains challenging with limited FDA-approved options. Emerging treatments like ketamine and cannabinoids offer hope for…